37
Conclusions 1- The search for the best molecular target in leukemia therapy points again at fusion proteins 2- Fusion proteins alter epigenetic regulation of target genes by recruiting enzymes 3- Enzyme inhibitors are being tested in clinical trials 4- The use of blocking peptides could contribute to neutralize oncogenic proteins